Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

One GP's fight to preserve core values

NICE is battling to retain its credibility with GPs after coming under intense political pressure to backtrack on its decision to rule against four Alzheimer's treatments.

Health minister Dr Stephen Ladyman this week challenged NICE's decision on the drugs, insisting it had not looked at all the evidence and had failed to take into account the wider social implications.

But Professor Alan Maynard, one of the institute's architects, told Pulse: 'If it gave in to this pressure it would undermine the whole way NICE works.' Professor Maynard, professor of health economics at the University of York, warned NICE had been set up to make difficult rationing decisions and the NHS 'can't fund everything'.

Patient groups and psychiatrists are united against the provisional decision to rule out the use of donepezil, rivastigmine, galantamine and memantine, but NICE insisted it has not been instructed to reverse its decision. GP prescribing experts doubted whether NICE could remain independent from political influence.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say